Exec Chat: Ligence CFO Addresses The Challenges Faced By An Early-Stage AI Company
Executive Summary
Medtech Insight spoke to the chief financial officer of Ligence, a Lithuanian start-up developing AI for echocardiography, to find out more about its commercial strategy, and problems it faces with commercialization.
You may also be interested in...
How The MDR Is Making The EU Competitively Backward
Pedantic versus pragmatic implementation of the EU MDR and its guidances, as well as notified bodies struggling with capacity and new processes, are creating a clunky, slow and expensive EU regulatory system that could damage EU industry, delegates heard at the RAPS Convergence meeting earlier this week.
GE Announces PAC Addition To Edison, And AWS Partnership
GE Healthcare has announced that it is releasing an AI-powered picture archive and communications system supported by Amazon Web Services.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.